Wolverine Trading »

Cytokinetics shares owned by Wolverine Trading

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Wolverine Trading from 13F filings

Historical chart of Wolverine Trading investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Wolverine Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Wolverine Trading

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.6M 114k 83.49
2016-06-30 $480 51 9.41

More positions owned by Wolverine Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Amazon (AMZN)
Apple (AAPL)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs Put Option (VOO)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Advanced Micro Devices (AMD)

View all positions for Wolverine Trading

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics